their SF levels were > 10,000 ng/mL. Three patients had disseminated histoplasmosis, two had disseminated tuberculosis, two had Clostridium difficile colitis (one had concurrent cytomegalovirus colitis and intestinal Kaposi's sarcoma), and one had disseminated Mycobacterium avium-Mycobacterium intracellulare infection. All but two of the patients were African-American. The mean SF level was higher for patients with disseminated histoplasmosis than for the other patients (>25,374 ng/mL vs. 14,545 ng/mL, respectively), but this difference was not statistically significant (P = .10; Mann-Whitney test). Although the proportion of African Americans in this cohort of patients (75%) was greater than it is in the overall HIV-infected population observed at the University During the period 1 July 1992-30 June 1996, 7,392 SF determinations were performed by the Diagnostic Hematology Laboratory, University of Cincinnati College of Medicine (Cincinnati). On one or more occasions, 26 patients were found to have SF levels of > 10,000 ng/mL. Seven of these patients were infected with HIV. An eighth HIV-infected individual with SF levels of >10,000 ng/mL was identified from the records of the Hematology/Oncology Section of the Cincinnati Veterans Affairs Medical Center.
The records of these patients were reviewed at the time that SF levels were determined, and the data are summarized in table 1. All patients were hospitalized with febrile illnesses at the time that of Cincinnati Medical Center (22%), this difference is also not statistically significant (P = .13; Fisher's exact test).
Our results suggest that SF levels of > 10,000 ng/mL in HIVinfected patients are a nonspecific indicator of significant superimposed infection, rather than a specific marker for a specific clinical syndrome. Elevated SF levels in general appear to be a marker for relatively advanced HIV disease with low CD4 cell counts, the presence of opportunistic infections, and limited survival [4, 5] , so the finding that high SF levels are nonspecific markers is not unexpected. Our results suggest that an SF level of >10,000 ng/mL in an HIVinfected patient should prompt an aggressive search for a specific infection; however, since we observed this finding only in hospitalized, febrile HIV-infected patients, it is unclear whether this laboratory test result would add anything to the evaluation already indicated by the patient's clinical circumstances. Cytomegalovirus (CMV) infection of the CNS is rarely observed in immunocompetent infants after the first month of life [1] . Until recent molecular techniques became available, this infection was diagnosed exclusively on the basis of the results of CSF culture and of immunohistochemical studies of a brain biopsy specimen. The outcome of this infection was poor in most instances but improved when ganciclovir became available. We describe a patient with CMV encephalitis who recovered after receiving treatment with ganciclovir.
A 6-week-old boy was born in the city hospital of Sint Nicolas after a normal term delivery. His mother had been treated with amoxicillin/clavulanic acid for postpartum endometritis; her bacterial cultures were negative. The infant was breast-fed during the first week of life. From the age of 5 weeks, convulsions of the right arm and leg were noted; these convulsions evolved to generalized convulsions.
Laboratory investigations at the age of 5 weeks revealed a normal complete blood cell count and an increased level of C-reactive protein (25 mg/L). Examination of the CSF revealed a WBC count of 2/mm3, an increased protein level (472 mg/dL), and a low glucose level (3 mg/dL). No C-reactive protein was found in CSF, and bacterial cultures were sterile. The serum CMV IgM titer was 1.5 AU/mL (positive, >0.5 AU/mL), and the CMV IgG titer was 73.4 AU/mL (immune, > 15 AU/mL).
The patient's clinical condition did not improve after iv treatment with cefotaxime, dexamethasone, and phenobarbital was administered, and the infant was transferred to our hospital. A physical examination revealed fever (temperature, 38°C), generalized hypotonia, and frequent myoclonic convulsions of the right arm. The WBC count and serum C-reactive protein level were within normal limits. Examination of the CSF revealed a WBC count of 940/mm3 (47% monocytes, 27% lymphocytes, 24% neutrophils, and Zolo plasma cells) and confirmed the high protein (708 mg/dL) and low glucose (2 mg/dL) concentrations. Antibiotic treatment consisted of cefotaxime (50 mg/kg every 6 hours), ampicillin (25 mg/kg every 6 hours), and a 4-day course of tuberculostatic drugs for possible bacterial meningitis.
A CT scan of the brain showed ventricular dilatation and a periventricular low-density lesion in the deep white matter of the right parieto-occipital region that was confirmed by an MRI scan. Bacterial and serial viral cultures (including those for CMV) of urine, saliva, and CSF as well as PCR for detection of herpes simplex in the CSF remained negative. An electroencephalogram showed bilateral high voltage paroxysmal discharges. The patient had progressive hydrocephaly and protracted convulsions. Nine days after admission, cultures of saliva yielded CMV. On day 11, CMV was detected in the CSF by PCR (this procedure was previously described by Bale et al. [2] .
Antibiotic treatment was stopped, and therapy with ganciclovir (5 mg/kg every 12 hours) was started. No side effects were observed during 31 days of treatment. During antiviral treatment, the convulsions disappeared, CSF values progressively normalized, and the epileptic discharges on the electroencephalogram disappeared. The child had no neurologic impairments at the age of 3 years. Serum CMV IgM antibodies were not detected 8 weeks postpartum, although CMV IgG antibodies were detected in the mother. The patient's immunoglobulins, IgG subclasses, and T cell subsets were normal; antibodies to HIV were not detected.
In our patient's case, the diagnosis of CMV meningoencephalitis was suggested by the periventricular lesion found on the CT and MRI scans, the CSF findings, and the positive specific serum IgM titers; however, this diagnosis was questioned because serial viral cultures of urine, saliva, and CSF remained negative and because CSF findings were compatible with bacterial meningitis. CSF findings in immunocompetent patients with CMV encephalitis are variable, and the absence of viruria does not rule out CNS infection [3] . Recently, identification of viral DNA in CSF by PCR, as was done in our case, has proved to be a reliable marker of CNS involvement [4] and has replaced more cumbersome and invasive methods [5] .
Since no cultures were performed in the first 2 weeks of life, the etiology of our patient's infection remains uncertain. The absence of periventricular calcifications suggests a postnatal infection or a congenital infection during late pregnancy. In the event of a congenital infection, the absence of viruria and generalized infection and the regression of the neurological symptoms would be unusual. It is unlikely that our patient acquired CMV infection postnatally through breast milk since he was nursed for a short period; like nosocomial infection, CMV infection acquired postnatally usually remains asymptomatic [1, 6] . Although ganciclovir therapy is not efficacious in AIDS patients, it has been shown to be efficacious in immunocompetent patients with CMV encephalitis [3, 5, 7] .
The present case illustrates that CMV encephalitis should be considered in the differential diagnosis for patients with protracted convulsions even if CSF findings suggest bacterial infection and viral cultures remain negative. Our case highlights the value of PCR for establishing the diagnosis of CMV encephalitis and demonstrates that immunocompetent patients with this infection may be successfully treated with ganciclovir.
